Medication info
Piobiar Tablet 100/30 mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Piobiar Tablet 100/30 mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
Korea HuTex Pharmaceuticals Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 202302356 · Approved 2023.08.08 · Insurance code 649105800

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. If the eGFR is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required. Do not administer this drug if the eGFR is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
Korea HuTex Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling blood sugar levels when taken in combination with sitagliptin and pioglitazone. Taking this medication along with dietary and exercise therapy enhances blood sugar management. It helps maintain stable blood sugar levels, supporting a healthy lifestyle.

Dosage and Administration

Adult dosage

One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. If the eGFR is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required. Do not administer this drug if the eGFR is less than 45 mL/min/1.73m2.

Precautions

This medication contains sitagliptin and pioglitazone and is used for diabetes treatment. Sitagliptin can rarely cause serious allergic reactions. Therefore, if symptoms such as rash, difficulty breathing, or swelling of the face or tongue occur within three months of administration, the medication should be discontinued immediately and medical consultation should be sought. Additionally, sitagliptin may cause acute pancreatitis, so if symptoms like upper abdominal pain, vomiting, or loss of appetite occur, medical attention should be sought immediately. Pioglitazone may cause fluid retention, exacerbating heart failure, so patients with heart failure or a history of heart failure should not take this medication. When taking pioglitazone, watch for symptoms of swelling or shortness of breath, and consult a doctor if these symptoms occur. This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and immediate medical attention should be sought if gross hematuria or urination issues arise. Patients with severely impaired kidney or liver function must consult a doctor before taking this medication, and dosage adjustment may be necessary if kidney function is decreased. It is safest for women who are pregnant or could become pregnant to avoid taking this medication. While taking this medication, signs of hypoglycemia (dizziness, cold sweat, severe fatigue, etc.) may occur, so caution is advised, especially when taken with other diabetes medications. Furthermore, this medication may cause side effects such as headache, upper respiratory tract infections, edema, weight gain, dyspepsia, etc. Therefore, if any unusual symptoms persist, medical consultation should be sought. Prior to taking this medication, it is essential to inform the doctor of your medical history and any medications currently being taken, and to regularly undergo blood tests and liver function tests.

Side effects

Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, congestive heart failure, fluid retention, edema, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-associated arthralgia, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, dyspepsia, dizziness, increased serum triglycerides, gastritis, elevated liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, rash, urticaria, cutaneous vasculitis, increased serum creatinine, anxiety, insomnia, drowsiness, herpes simplex, blurred vision, hypertension, heart failure, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, weight gain, urinary tract infection, low back pain, dizziness, abdominal distension, elevated serum creatine kinase, sinusitis, chest pain, fatigue, weakness, dyspnea, itching, chest discomfort, tremors, chills, gastrointestinal disease, epigastric discomfort, numbness, muscle rigidity, head discomfort, exacerbation of liver disease, knee abnormalities, arm weakness, proteinuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly-closed container to prevent air and moisture from entering, at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness for longer periods.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.